SNM Annual Meeting Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     




J Nucl Med. 2008; 49 (Supplement 1):291P
This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chirakal, R.
Right arrow Articles by Saab, C.
PubMed
Right arrow Articles by Chirakal, R.
Right arrow Articles by Saab, C.

Radiopharmaceutical Chemistry: New Chemistry-Oncology

New Chemistry-Oncology Posters

[18F]6-Fluoro-D-DOPA: A new PET tracer for the detection of melanoma

Raman Chirakal1, Rezwan Ashique1, Troy Farncombe1, Byram Bridle2 and Chantal Saab1

1 Nuclear Medicine, Hamilton Health Sciences, Hamilton, Ontario, Canada; 2 Centre for Gene Therapeutics, McMaster University, Hamilton, Ontario, Canada

1240

Objectives: To investigate the use of [18F]6-fluoro-D-DOPA for the detection of melanoma.

Methods: D- and L- enantiomers of [18F]6-FDOPA were prepared by the direct fluorination of D-and L-DOPA, respectively, in BF3/aHF. B16-F10 melanoma cells (106) grown in complete MEM/F11 medium were tryspsinized and placed on a shaker for six hours to allow re-expression of the surface proteins. They were washed with HBSS buffer and incubated with 500 µCi [18F]6-FDOPA (D- and L-) for 120 min at 37 oC. Cells were centrifuged and washed with HBSS buffer until less than 10% of the total 18F remained in the supernatant. 500 µCi (0.2 mL) of [18F]-labelled D- and L-6FDOPA was injected into the tail veins of B16-F10 melanoma mice after they were anesthetized with isoflurane. PET Images were obtained using a Phillips Mosaic PET scanner and co-registered with CT from a X-SPECT Scanner. Images were reconstructed and time activity curves were obtained for various organs.

Results: 18F uptake in the tumor cells were similar, 20 and 22%, for D- and L- [18F]6-FDOPA, respectively. PET images B16-F10 melanoma mice showed clear delineation of the tumor 120 min after[18F]6-Fluoro-D-DOPA injection. Time activity curves showed slow clearance of 18F from the tumor during the first 45 min and then remained constant.

Conclusions: [18F]-labelled 6-fluoro-D-DOPA is an excellent tracer for the delineation of melanoma. Preliminary results indicate that D-FDOPA behaves like a false precursor of melanin. Use of D-[18F]6-FDOPA would alleviate all problems associated with the formation, in vio, of metabolites from L-[18F]6-FDOPA.

Research Support: We thank Dr. Karen Gulenchyn and Ms. Carol Dunne of HHS for their support.





This Article
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Chirakal, R.
Right arrow Articles by Saab, C.
PubMed
Right arrow Articles by Chirakal, R.
Right arrow Articles by Saab, C.